fructose-1,6-diphosphate and Osteoporosis, Postmenopausal

fructose-1,6-diphosphate has been researched along with Osteoporosis, Postmenopausal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, YP; Hu, YY; Ma, B; Wang, YL; Wu, D; Yang, ZD; Ying, HJ; Zhang, Q; Zheng, YY	1

Other Studies

1 other study(ies) available for fructose-1,6-diphosphate and Osteoporosis, Postmenopausal

Article	Year
Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. Acta pharmacologica Sinica, 2012, Volume: 33, Issue:4 Topics: Animals; Bone and Bones; Bone Density; Female; Fructosediphosphates; Humans; Immunologic Factors; Insulin-Like Growth Factor I; Osteoporosis, Postmenopausal; Osteoprotegerin; Oxidative Stress; RANK Ligand; Rats; Rats, Sprague-Dawley; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction	2012

Article

Year

Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway.

Acta pharmacologica Sinica, 2012, Volume: 33, Issue:4

Topics: Animals; Bone and Bones; Bone Density; Female; Fructosediphosphates; Humans; Immunologic Factors; Insulin-Like Growth Factor I; Osteoporosis, Postmenopausal; Osteoprotegerin; Oxidative Stress; RANK Ligand; Rats; Rats, Sprague-Dawley; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction

2012